✕
✕

FRONTEO's drug discovery support AI technology was introduced in the Nikkei Sangyo Shimbun on October 10th.

Home » corporate » News » 2020 » FRONTEO's drug discovery support AI technology was introduced in the Nikkei Sangyo Shimbun on October 10th.
HOME/ Company/ News/ 2020/ FRONTEO's drug discovery support AI technology was introduced in the Nikkei Sangyo Shimbun on October 10th.
2020.10.14 Media information

- -

FRONTEO's drug discovery support AI technology was introduced in the Nikkei Sangyo Shimbun on October 10th.

The drug discovery support AI developed by FRONTEO in the "Monthly Editing Special" of the Nikkei Sangyo Shimbun (page 2020) dated October 10, 14.Cascade EyeWas introduced.

 

"Cascade Eye" is a system that expresses genes and molecules related to diseases in a pathway map, which improves the efficiency of drug discovery target (gene) search, discovers the possibility of diversion of existing drugs, and identifies biomarkers. And so on.